(1R,2R)-Cyclohexane-1,2-Dicarboxylic Acid Bulk Price Procurement
Analyzing Bulk Price Variations Against Sigma-Aldrich MM 8244490250 Listings for CAS 46022-05-3
Procurement managers evaluating (1R,2R)-Cyclohexane-1,2-Dicarboxylic Acid often encounter significant price disparities between catalog listings and industrial-scale contracts. Catalog prices, such as those referenced under MM 8244490250, typically reflect gram-scale research quantities with substantial markup for immediate availability and small-unit packaging. In contrast, bulk price procurement for CAS 46022-05-3 is driven by production batch sizes, raw material sourcing efficiency, and logistical consolidation.
When transitioning from laboratory synthesis to commercial manufacturing, the cost per kilogram decreases non-linearly. This is due to the optimization of the synthesis route and the amortization of purification costs over larger volumes. Buyers should note that catalog listings rarely account for the custom processing required for industrial purity standards needed in API production. At NINGBO INNO PHARMCHEM CO.,LTD., we structure pricing based on committed volume tiers rather than static catalog rates, ensuring alignment with your production schedule rather than spot market fluctuations.
Critical COA Parameters and Enantiomeric Purity Validation Beyond Standard 98% Grades
For chiral intermediates, a standard 98% purity claim on a Certificate of Analysis (COA) is insufficient for high-stakes pharmaceutical applications. The critical differentiator lies in the enantiomeric excess (ee%) and the specific optical rotation. While general chemical suppliers may list bulk purity, the presence of the (1S,2S) enantiomer or cis-isomers can critically impact downstream reactions, particularly when this compound serves as a Lurasidone intermediate.
Validation must extend beyond HPLC area normalization. We recommend requesting chiral HPLC or GC data specifically quantifying the opposite enantiomer. Furthermore, optical rotation values should be verified against specific solvent conditions, typically acetone, as concentration variations can skew results. As a Pharmaceutical synthon, the consistency of this parameter is vital. Our quality assurance protocols include batch-specific validation to ensure that the chiral integrity remains intact throughout the crystallization process, preventing racemization that could compromise final drug efficacy.
Bulk Packaging Configurations and Hygroscopic Stability Controls for (1R,2R)-Cyclohexane-1,2-dicarboxylic Acid
Physical stability during transit is as critical as chemical purity. (1R,2R)-Cyclohexane-1,2-dicarboxylic Acid exhibits moderate hygroscopicity, meaning exposure to ambient humidity during shipping can lead to clumping or surface hydrolysis. Standard catalog packaging often utilizes simple polyethylene bags within cardboard boxes, which may not suffice for multi-month storage or humid transit routes.
For bulk orders, we utilize double-lined high-density polyethylene (HDPE) bags sealed within fiber drums or woven polypropylene bags with inner liners. This configuration minimizes moisture ingress. It is essential to discuss Custom packaging requirements early in the procurement cycle. If you are shipping to regions with high humidity, nitrogen flushing of the inner packaging is recommended to maintain free-flowing properties. We focus strictly on physical packaging integrity to ensure the product arrives in the same state it left the facility, without making regulatory environmental claims.
Technical Specification Variance: Melting Point and Density Deviations in Large-Scale Batches
Large-scale production batches can exhibit slight variances in physical constants compared to small-scale laboratory preparations. The reference melting point for this compound is approximately 184 °C. However, in industrial crystallization, the rate of cooling and agitation speed can influence crystal lattice formation, potentially shifting the observed melting range by 1-2 °C. Similarly, bulk density may vary depending on the milling process used post-crystallization.
From a field engineering perspective, a non-standard parameter often overlooked is the thermal degradation threshold during vacuum drying. While the boiling point is predicted around 384 °C, prolonged exposure to temperatures above 100 °C during the drying phase can induce minor decarboxylation or racemization, affecting the optical rotation. This is not typically listed on a standard COA but is critical for process engineers designing drying cycles. The following table outlines typical technical parameters compared against standard catalog expectations:
| Parameter | Standard Catalog Specification | Bulk Industrial Specification | Validation Method |
|---|---|---|---|
| Purity (HPLC) | >98% | >98.5% (Typical) | Area Normalization |
| Melting Point | 184 °C | 183-185 °C | DSC / Capillary |
| Optical Rotation | -18 ° (C=1, Acetone) | -17.5 ° to -18.5 ° | Polarimetry |
| Moisture Content | Not Always Specified | <0.5% (Karl Fischer) | Karl Fischer Titration |
| Particle Size | Undefined | Customizable (e.g., <100 mesh) | Sieve Analysis |
Please refer to the batch-specific COA for exact numerical values as these can shift based on the production run.
Purity Grade Scalability: Ensuring 98%+ Consistency Across Multi-Kilogram Orders Versus Catalog Listings
Scalability is the primary challenge in transitioning from gram-scale research to tonnage production. A supplier capable of providing 100g of Chiral dicarboxylic acid at 99% purity may struggle to maintain that specification across 500kg due to heat transfer limitations in larger reactors. Consistency is maintained through strict process control parameters rather than post-production blending.
At NINGBO INNO PHARMCHEM CO.,LTD., we ensure that the industrial purity levels match or exceed catalog specifications by maintaining identical crystallization solvents and drying protocols regardless of batch size. This ensures that your process validation data remains applicable when scaling up. For detailed information on application specifics, you may review our insights on Sourcing (1R,2R)-1,2-Cyclohexanedicarboxylic Acid For Lurasidone Synthesis. To verify current stock levels and technical data for your specific volume requirements, please visit our product page for (1R,2R)-Cyclohexanedicarboxylic Acid.
Frequently Asked Questions
What is the standard lead time for bulk orders of CAS 46022-05-3?
Lead times vary based on current inventory and production scheduling. Standard ex-stock items ship within 5-7 business days, while made-to-order batches typically require 3-4 weeks for production and quality validation.
Can you provide a COA before shipment for verification?
Yes, a preliminary COA from the production batch can be provided for technical review prior to final shipment. Please refer to the batch-specific COA for final confirmed values upon delivery.
What packaging options are available for humid climates?
We offer double-lined HDPE bags with aluminum foil inner liners and nitrogen flushing to prevent moisture absorption during transit to high-humidity regions.
Is the material supplied suitable for GMP manufacturing?
We provide high-purity grades suitable for pharmaceutical synthesis. Specific GMP documentation requirements should be discussed directly with our quality assurance team during the qualification process.
Sourcing and Technical Support
Securing a reliable supply chain for chiral intermediates requires a partner who understands both the chemical nuances and the logistical demands of bulk procurement. By focusing on technical specification variance, packaging stability, and scalable purity, we ensure your production lines remain uninterrupted. Ready to optimize your supply chain? Reach out to our logistics team today for comprehensive specifications and tonnage availability.